general conditions of use
privacy statement
imprint
© 2007 Bayer HealthCare Pharmaceuticals

 


Physician Support
Transurethral Resection of the Prostate (TURP)
   
     
 

Viadur is indicated in the palliative treatment of advanced prostate cancer. Bayer is not responsible for, and does not endorse, any of the information found on this page.

Treatment Options

Chemotherapy
  Cryosurgery
  Hormone therapy
  Radiation therapy
  Radical prostatectomy
  Transurethral resection of the prostate (TURP)
  Watchful waiting

There are many treatments for prostate cancer. The best one for you depends on a number of factors. These include your age, your overall health, and the stage and grade of your cancer.

Be sure to discuss the possible benefits, risks and side effects with each option. The sections here outline some of the general risks and side effects. However, your doctor is the best source of information on your condition. Before you and your doctor select any treatment approach, risks and benefits should be thoroughly discussed.Take the time to research all of your treatment options. Consider getting a second opinion before making a final decision. The most common treatment options for prostate cancer include watchful waiting, radiation, and hormone therapy.

Transurethral Resection of the Prostate

Transurethral resection of the prostate (TURP) is another surgical technique performed under anesthesia through a fiberoptic instrument that is inserted into the penis.1 The physician can look through the instrument to see prostate tissue that is blocking urinary flow through the urethra.2 The physician then removes the prostate tissue with the instrument leaving behind the prostate’s "shell."3 No incision is needed, and a catheter will be left in place for a few days until any urinary bleeding resolves.4

This procedure may be done to relieve symptoms before other treatments begin. It is not done to cure the disease or to remove the cancer. It is often used to relieve the symptoms of non-cancerous prostate enlargement.5

What are possible side effects: Possible leaking urine. Incontinence and impotence are not generally associated with a TURP.6

Who makes a good candidate: Men who are not candidates for radical prostate surgery.

Viadur is indicated in the palliative treatment of advanced prostate cancer.

 


Printer-Friendly Version


References

Important Safety Considerations
Viadur is contraindicated in patients with hypersensitivity to Gn-RH, Gn-RH agonist analogs, or any of the components in Viadur.

Viadur is contraindicated in women and pediatric patients and was not studied in women or children.

Viadur, like other LH-RH agonists, causes a transient increase in serum concentrations of testosterone during the first week of treatment. Patients may experience a worsening of symptoms or onset of new symptoms including bone pain, neuropathy, hematuria, or ureteral or bladder outlet obstruction, and spinal cord compression.

The most comment systemic side effects were hot flashes (67.9%), asthenia (7.6%), gynecomastia (6.9%), depression (5.3%), and sweating (5.3%). The most common local side effects were bruising (34.6%) and burning (5.6%).


Distributed and Marketed by:

Manufactured by:

Bayer HealthCare Pharmaceuticals
6 West Belt, Wayne, NJ 07470 USA

© Copyright 2007 Bayer HealthCare Pharmaceuticals. Viadur is a trademark of ALZA Corporation under license to Bayer HealthCare Pharmaceuticals. DUROS® is a registered trademark of ALZA Corporation.

The information provided on Bayer products is only intended for the United States audience. Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) also may be different in different countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the United States.